Education

Biography

Zeev Blumenfeld is MD for Hebrew University and Hadassah Medical School, Jerusalem, and he is the Director for Reproductive Endocrinology for the department Obstetrics & Gynecology. He worked as Director in the year 2010 for Reproductive Endocrinology; he is a Senior Physician for Reproductive Endocrinology and Infertility, OB/GYN. He has an extensive and vast teaching experience in the field of "Reproductive Endocrinology".
He taught Director of Endocrinology Course for medical & graduate students, Director of “Physiology of Reproduction” course. He worked as a Reviewer for many scientific Journals. He also has membership for International and National professional societies. He Elected as member of the "Society for Gynecologic Investigation". Worked as Editor in Chief- ‘Clinical Medicine Insight: Reproductive Health’, "Journal of Reproductive Biology and Health".
Zeev Blumenfeld advanced studies: 1983-1985 Fellowship in Reproductive Endocrinology in the Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco,
1993- Exon-Intron Workshop on Molecular Biology - Recombinant DNA Methodology, 1993.
2014-   Completed the program of GCP & clinical trials management for PI's. He had 27 Publications.

Research Interest

• Research Gate score 43.99.Over 17,000 publication views.
• Prevention of premature ovarian failure (POF) in young women receiving gonadotoxic chemotherapy.
• Reproductive Endocrinology
• Inhibin & Activin in Human Reproduction
• Hypophysiotropic and Neuregulatory Modulation of Fetal Human Pituitary.
• Infertility and Assisted Reproduction (ART)
• Immunologic Problems in Infertility

Professional Activities:

Publications

1. Hertzberg EH, Ariel N, Kaplan D, Markovitz M, Blumenfeld Z (2015) Cervical Cytology Screening – Is the Change of Policy Risk Free?  Int J Cancer Clin Res. 2015; 2: 31-6.
2. Bronshtein M, Blumenfeld Z, Naroditsky I, Gover A.Outcome of a right aortic arch diagnosed in utero.Prenat Diagn. 2015 Dec 29. doi: 10.1002/pd.4763.
3. Blumenfeld Z. Why more is less and less is more when it comes to ovarian stimulation. J Assist Reprod Genet. 2015 Oct 19.
4. C,D-Younis, J, Shukha, M, Ben-Ami, M , Izhaki, I , Blumenfeld, Z , Brenner, B, Sarig G. Prospective Evaluation of the Protein C Global Assay during Pregnancy Following Assisted Reproduction. Obstet.Gynecol. 2010; 115:969-74.
5. A,B,C,D-Blumenfeld Z. Fertility Treatment in Women with Premature Ovarian Failure. Expert Rev. Obstet. Gynecol. 2011; 6; 321–330.
6. Blumenfeld Z, Mischari O, Schultz N, Boulman N, Balbir-Gurman A. Gonadotropin Releasing Hormone Agonists May Minimize Cyclophosphamide associated Gonadotoxicity in SLE and Autoimmune Diseases. Semin Arthritis Rheum.2011;41: 346-52
7. Bronshtein M, Zimmer Z, Blazer S, Blumenfeld Z. Right Ductus Arteriosus- Facts and Theory. Eur J Obstet Gynecol. 2011; 159: 282–288.
8. Dann EJ, Blumenfeld Z, Bar-Shalom R, Avivi I, Ben-Shachar M, Goor O, Libster D, Gaitini D, and Rowe JM, Epelbaum R. A 10-year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.Am J Hematol. 2012 ;( 87)1:32-6.
9. Blumenfeld Z. Chemotherapy and Fertility. Best Pract Res Clin Obstet Gynaecol.2012; 26:379–90.
10. Zimmer Z, Blazer S, Blumenfeld Z, Bronshtein M. Fetal Transient Clitoromegaly and Transient Hypertrophy of Labia Minora in Early and Mid Pregnancy. J Ultrasound Med. 2012; 31:409-15.
11. Blumenfeld Z.Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.Oncologist. 2012; 17:162-3.
12. Bronshtein M, Zimmer EZ, Blazer S, Blumenfeld Z. Transient abnormal fetal cardiac flow patterns at 13 to 17 gestational weeks. Prenat Diagn. 2012; 32:444-9.
13. Blumenfeld Z. Epigenetics and vitrification of embryos: one step forward and many raised equivocal questions. Fertil Steril. 2012; 98: 41-2.Invited Commentary on "Effect of 5-aza-2'-deoxycytidine on methylation of the putative imprinted control region of H19 during the in vitro development of vitrified bovine two-cell embryos".
14. Blumenfeld Z. GnRH-a for Preservation of Ovarian Function during (Neo) Adjuvant Chemotherapy for Breast Cancer" - J Clin Oncol. 2012; 30:3310.
15. Blumenfeld Z, Patel B, Leiba R, Zuckerman T. Gonadotropin Releasing Hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation. Fertil Steril, 2012;98:1266-70
16. Khatib N, Blumenfeld Z, Bronshtein M. Early Prenatal Diagnosis of Tricuspid Stenosis," Am J Obstet Gynecol. 2012; 207(5):e6-8.
17. Blumenfeld Z. Preservation of ovarian function and fertility despite gonadotoxic chemotherapy. Expert Review Endocrinol Metabol 2012; 7: 567-76.
18. Tripto-Shkolnik L, Blumenfeld Z, Bronshtein M, Salmon A, Jaffe A. Pregnancy in a Patient with Adrenal Carcinoma Treated with Mitotane: A Case Report and Review of Literature.J Clin Endocrinol Metab. 2013; 98:443-7.
19. Blumenfeld Z,Katz G, Evron A. "An ounce of prevention is worth a pound of cure"- The case for and against GnRH-agonist for fertility preservation.  Annals of Oncology, 2014; 25: 1719-28.
20. Bronshtein M, Solt I, Blumenfeld Z. The advantages of early mid trimester targeted fetal systematic organ screening for the detection of fetal anomalies-will a global change start in Israel? Harefuah. 2014; 153:320-4, 368. Hebrew.
21. Blumenfeld Z, Khatib N, Zimmer EZ, Bronshtein M. Fetal demise in the early second trimester: sonographic findings. J Clin Ultrasound. 2015; 43:109-122.
22. Blumenfeld Z, Evron A. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists. Expert Opin Pharmacotherapy. 2015; 16:1009-20.
23. Blumenfeld Z. Inadvertent premature humanchorionic gonadotropin administration does not prevent folliculogenesis and in vitro fertilization. IVF Lite 2015; 2:64-6.
24. Blumenfeld Z.Does freeze all policy eliminate OHSS??? "It ain't necessarily so…”J Assist Reprod Genet. 2015; 32:1571.
25. Blumenfeld Z, Zur H, Dann EJ.Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.Oncologist. 2015; 20:1283-9.
26. C,D-Bronshtein M, Khatib N, Blumenfeld Z, Prenatal Diagnosis and Outcome of Isolated Interrupted Inferior Vena Cava. Amer. J. Obstet. Gynecology. Am. J. Obstet. Gynecol. 2010; 202:398.e1-4. 
27. A,B,C,D-Blumenfeld Z, Zuckerman T. Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist. Oncologist. 2010; 15:59-60.